[Rheumatoid arthritis associated interstitial lung disease].

Rev Invest Clin

Servicio de Enfermedades Intersticiales del Pulmón, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, México, D.F.

Published: April 2013

Download full-text PDF

Source

Publication Analysis

Top Keywords

[rheumatoid arthritis
4
arthritis associated
4
associated interstitial
4
interstitial lung
4
lung disease]
4
[rheumatoid
1
associated
1
interstitial
1
lung
1
disease]
1

Similar Publications

Provide real-world data on switching from adalimumab biosimilar MSB11022 to GP2017 related to persistence, adherence, and safety in adult patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), and axial spondyloarthritis (axSpA). Retrospective cohort study that used registries and medical records from a single hospital (June 2022 to April 2024). Adult patients with RA, PsA, and axSpA treated with adalimumab biosimilar MSB11022 who switched to biosimilar GP2017 were identified and followed up until April 2024, or disenrollment.

View Article and Find Full Text PDF

Objective: While earlier research has indicated that trans fatty acids (TFAs) are detrimental to cardiovascular health as well as other conditions, the purpose of this study is to look into any possible connections between trans fatty acids and rheumatoid arthritis (RA).

Methods: The NHANES database provided the data for this study, covering two periods: 1999-2000 and 2009-2010. The correlation between plasma TFAs (linolelaidic acid, vaccenic acid, palmitelaidic acid, and elaidic acid) and RA was examined using weighted univariate and multivariate regression analyses as well as analysis of subgroups.

View Article and Find Full Text PDF

Introduction Osteoarthritis and rheumatoid arthritis, two of the most common forms of arthritis worldwide, are chronic diseases affecting the joints. The Rio Grande Valley is characterized by an abundance of health disparities, with previous studies showing increased rates of multiple diseases and disorders in this region. This study aimed to determine both the prevalence and the risk-adjusted average cost of osteoarthritis and rheumatoid arthritis in the Rio Grande Valley and to compare them with the national average.

View Article and Find Full Text PDF

A Network Analysis of Quality of Life Among Older Adults With Arthritis.

Int J Older People Nurs

January 2025

School of Nursing and Research Institute of Nursing Science, Hallym University, Chuncheon, Gangwon-do, South Korea.

Introduction: Arthritis, one of the most common chronic diseases among older people, greatly impairs quality of life through a variety of physical and psychological challenges. This study used network analysis to gain a deeper understanding of the relationships between the indicators of quality of life in older adults with arthritis depending on duration of disease.

Methods: This cross-sectional study used data from 874 older adults with osteoarthritis and/or rheumatoid arthritis who answered the eighth (2019-2021) Korea National Health and Nutrition Examination Survey.

View Article and Find Full Text PDF

Hydrolysis of 2D Nanosheets Reverses Rheumatoid Arthritis Through Anti-Inflammation and Osteogenesis.

Adv Mater

December 2024

Department of Orthopedics, Shanghai Tenth People's Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, The Institute for Biomedical Engineering & Nano Science School of Medicine, School of Medicine, Tongji University, Shanghai, 200072, P. R. China.

Rheumatoid arthritis (RA) is a kind of inflammation homeostasis disorder that dysfunctions the joints. Clinically, medications against RA focus simply on mitigating the focal inflammation, without considering pro-osteogenesis re-modeling of the bone microenvironment. In the present work, 2D layered calcium disilicide nanoparticles (CSNs) are fabricated by facile aqueous exfoliation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!